This interview and post was originally produced by The IT Media Group.
Executive Insights is a videocast series featuring exceptional leaders. Nasheen Liu, Partner and SVP of CIO Program Strategy at The IT Media Group speaks with senior IT and business executives across industries to share best practices for navigating through challenging times.
This episode features Philip Poulidis, CEO & Co-Founder of ODAIA, a Toronto-based AI start-up that’s already making an impact in the digital health space. We explore the digital pivot in the pharmaceutical industry and why data and AI-powered decision-making is critical for finding efficiencies in pharmaceutical sales activities. Philip offers his perspective about how to embrace technology as an opportunity for those in the industry who might be reluctant to change.
ODAIA has innovated the first AI-powered Customer Data Platform (CDP) that pioneered the combination of process mining, customer journey mapping and AI to deliver goal-driven commercial insights and process automation as a SaaS. ODAIA offers a self-serve platform: MAPTUAL, serving the biopharma industry.
The global pandemic has changed the customer-facing pharma business, forever. With direct access more difficult than ever, and HCP preferences shifting permanently toward digital engagement and personalized support, digital transformation is now a main priority.
A digital tool that makes next best action recommendations, identifies HCP receptiveness and targets effective omnichannel actions in order to achieve desired objectives.Our Solution
Let data-driven insights help you level up and connect with HCPs better, faster, and more effectively, so that the patients who need therapeutics receive them when they are needed most.
Watch our experts explain how MAPTUAL creates a unified experience with meaningful touchpoints
to better engage with your HCPs.